Literature DB >> 16341147

Cell reservoirs in lymph nodes infected with HIV-1 subtype E differ from subtype B: identification by combined in situ polymerase chain reaction and immunohistochemistry.

Lertlakana Bhoopat1, Tat S Rithaporn, Surapan Khunamornpong, Tanin Bhoopat, Clive R Taylor, Paul S Thorner.   

Abstract

In Thailand, the predominant HIV subtype is E, rather than subtype B as in North America and Europe. Subtype E has the ability to replicate in vitro in Langerhans cells. We hypothesized that this cell type might constitute a reservoir for the HIV virus in infected lymph nodes. We examined lymph nodes from 25 HIV-1 subtype E-infected patients to determine the immunophenotype of HIV-1-infected cells, their numbers and their distribution. The presence of HIV was detected either by in situ reverse transcriptase-polymerase chain reaction or immunoperoxidase. Cell identity was determined by double labelling using alkaline phosphatase-based immunohistochemistry. The majority of HIV-infected cells in the lymph nodes were Langerhans cells (CD1a+S100+) and Langerhans-related dendritic cells (p55+S100+). These cells were located in the paracortical areas of lymph nodes, with a few cells scattered at the edges of germinal centers, but were absent from germinal centers themselves, in contrast to the reported distribution of subtype B virus. In addition, multinucleated giant cells were significantly more common in HIV-infected nodes (64%) compared to controls (4%) (P=0.00002). In conclusion, Langerhans histiocytes and related cells are reservoirs for HIV subtype E in lymph nodes. Disrupting the pathway of infection of Langerhans cells and related cells may be a viable strategy to interfere with transmission of HIV subtype E.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16341147     DOI: 10.1038/modpathol.3800527

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  14 in total

1.  Flow cytometry analysis of cell population dynamics and cell cycle during HIV-1 envelope-mediated formation of syncytia in vitro.

Authors:  Israel Torres-Castro; César N Cortés-Rubio; Guadalupe Sandoval; Edmundo Lamoyi; Carlos Larralde; Leonor Huerta
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-01-18       Impact factor: 2.416

2.  Human immunodeficiency virus type 1 subtype C Tat fails to induce intracellular calcium flux and induces reduced tumor necrosis factor production from monocytes.

Authors:  Grant R Campbell; Jennifer D Watkins; Kumud K Singh; Erwann P Loret; Stephen A Spector
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

3.  Differential induction of interleukin-10 in monocytes by HIV-1 clade B and clade C Tat proteins.

Authors:  Justine K Wong; Grant R Campbell; Stephen A Spector
Journal:  J Biol Chem       Date:  2010-04-08       Impact factor: 5.157

4.  Investigating the human immunodeficiency virus type 1-infected monocyte-derived macrophage secretome.

Authors:  Pawel Ciborowski; Irena Kadiu; Wojciech Rozek; Lynette Smith; Kristen Bernhardt; Melissa Fladseth; Mary Ricardo-Dukelow; Howard E Gendelman
Journal:  Virology       Date:  2007-02-22       Impact factor: 3.616

Review 5.  HIV Latency in Myeloid Cells: Challenges for a Cure.

Authors:  Alisha Chitrakar; Marta Sanz; Sanjay B Maggirwar; Natalia Soriano-Sarabia
Journal:  Pathogens       Date:  2022-05-24

6.  HIV-1 clade B Tat, but not clade C Tat, increases X4 HIV-1 entry into resting but not activated CD4+ T cells.

Authors:  Grant R Campbell; Erwann P Loret; Stephen A Spector
Journal:  J Biol Chem       Date:  2009-11-16       Impact factor: 5.157

Review 7.  Current progress in the development of a prophylactic vaccine for HIV-1.

Authors:  Lena J Gamble; Qiana L Matthews
Journal:  Drug Des Devel Ther       Date:  2010-12-22       Impact factor: 4.162

8.  Penicillium marneffei-stimulated dendritic cells enhance HIV-1 trans-infection and promote viral infection by activating primary CD4+ T cells.

Authors:  Yan Qin; Yuye Li; Wan Liu; Renrong Tian; Qianqian Guo; Shaoyou Li; Hongbin Li; Daojun Zhang; Yongtang Zheng; Li Wu; Ke Lan; Jianhua Wang
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

9.  MRN-100, an Iron-based Compound, Possesses Anti-HIV Activity In Vitro.

Authors:  Mamdooh Ghoneum; Magda Shaheen
Journal:  Evid Based Complement Alternat Med       Date:  2008-03-20       Impact factor: 2.629

Review 10.  What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine?

Authors:  Grant R Campbell; Erwann P Loret
Journal:  Retrovirology       Date:  2009-05-25       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.